Recent progress in the clinical development of thromboxane A2receptor antagonists
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543784.3.5.469
Reference62 articles.
1. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
2. Thromboxane A2 receptor antagonists
3. A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In silico design of a dual TPR/TxS inhibitor for venous thromboembolism and related cardiovascular diseases;Canadian Journal of Chemistry;2014-04
2. Prostanoid receptor antagonists: development strategies and therapeutic applications;British Journal of Pharmacology;2009-09
3. Overview of the Pharmacological Properties of Daltroban, a Thromboxane A2/Prostanoid-Receptor Partial Agonist;Cardiovascular Drug Reviews;1998-09
4. Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[{(4-chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists;Bioorganic & Medicinal Chemistry Letters;1998-08
5. Activation of thromboxane receptors and the induction of vasomotion in the hamster cheek pouch microcirculation.;British Journal of Pharmacology;1997-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3